# MaSTherCell to build commercial cell and gene therapy facility in Belgium

MaSTherCell SA signed a lease for a 5,700 m² facility in Gosselies, Belgium, for late-stage and commercial cell and gene therapy manufacturing. The facility is expected to be operational in early 2021 and will create several hundred jobs.

- Type: New facility
- Announced: 2019-03-26
- Where: Gosselies, Belgium, Belgium
- Starts operating: Q1 2021
- Status: announced
- Products: cell and gene therapies
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [MaSTherCell SA](https://endata.com/companies/38263.md)

## Sources

- [biospace.com](https://www.biospace.com/masthercell-sa-announces-creation-of-a-new-commercial-manufacturing-facility-for-cell-and-gene-therapies), 2019-03-26: "As a leading CDMO, MaSTherCell has a role to play in solving the current lack of commercial manufacturing capacities in Europe and we believe this facility will be a game changer for market access worldwide."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.